# A Community-Based Screening Program to Identify Participants at High Risk for Amyloid Pathology

> **NCT06043700** · — · ACTIVE_NOT_RECRUITING · sponsor: **Eisai Limited** · enrollment: 2000 (estimated)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT06043700
- **Lead sponsor:** Eisai Limited
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-09-12
- **Primary completion:** 2028-03-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06043700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06043700, "A Community-Based Screening Program to Identify Participants at High Risk for Amyloid Pathology". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT06043700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*